| Authors: |
McCutcheon RA; Department of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: robert.mccutcheon@psych.ox.ac.uk., Pillinger T; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; South London and Maudsley NHS Foundation Trust, London, UK., Varvari I; Department of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK., Halstead S; Medical School, The University of Queensland, Brisbane, QLD, Australia; Addiction and Mental Health Service, Metro South Health, Brisbane, QLD, Australia., Ayinde OO; Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria., Crossley NA; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile., Correll CU; Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempsted, NY, USA; The Feinstein Institute for Medical Research, Northwell Health, New Hyde Park, NY, USA; Charité - Universitätsmedizin Berlin, Berlin, Germany., Hahn M; Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Howes OD; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Kane JM; Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempsted, NY, USA; The Feinstein Institute for Medical Research, Northwell Health, New Hyde Park, NY, USA., Kabir T; Department of Psychiatry, University of Oxford, Oxford, UK., Konradsson-Geuken Å; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Swedish Schizophrenia Association, Stockholm, Sweden., Lennox B; Department of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK., Hui CLM; Department of Psychiatry, University of Hong Kong, Hong Kong Special Administrative Region, China., Rossell SL; Centre for Mental Health, Swinburne University of Technology, Melbourne, VIC, Australia., Solmi M; SCIENCES Lab, University of Ottawa, Ottawa, ON, Canada; Champlain First Episode Psychosis Program, The Ottawa Hospital, Ottawa, ON, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany., Sommer IE; University Medical Center Groningen, Groningen, Netherlands., Taipale H; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Niuvanniemi Hospital, Kuopio, Finland., Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Venkatasubramanian G; Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India., Warren N; Medical School, The University of Queensland, Brisbane, QLD, Australia; Addiction and Mental Health Service, Metro South Health, Brisbane, QLD, Australia., Siskind D; Medical School, The University of Queensland, Brisbane, QLD, Australia; Addiction and Mental Health Service, Metro South Health, Brisbane, QLD, Australia. |
